Not known Factual Statements About pentobarbital sodium price
Not known Factual Statements About pentobarbital sodium price
Blog Article
pentobarbital will decrease the level or effect of gefitinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will decrease the extent or outcome of armodafinil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Unfamiliar.
Caution when discontinuing CYP3A4 inducers which have been coadministered with hydrocodone; plasma concentrations of hydrocodone could improve and may lead to most likely lethal respiratory depression
This drug could improve the metabolism of estradiol when administered concurrently; individuals on oral contraceptives are becoming pregnant when concurrently taken care of with antiepileptic drugs; propose an alternate contraceptive strategy to Females having this drug
pentobarbital will reduce the extent or impact of levamlodipine by influencing hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will lower the level or impact of solifenacin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.
pentobarbital will decrease the extent or impact of clozapine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.
pentobarbital will lower the level or impact of maraviroc by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.
pentobarbital will lower the level or result of cyclosporine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.
Contraindicated (1)pentobarbital will lower the extent or outcome of naloxegol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Use of naloxegol with solid CYP3A4 inducers just isn't encouraged
pentobarbital decreases levels of elvitegravir/cobicistat/emtricitabine/tenofovir DF by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. May check here possibly lead to lack of virologic response and attainable resistance.
With therapeutic doses of TCAs, barbiturates improve metabolism and decrease blood concentrations of TCAs.
pentobarbital decreases effects of sufentanil SL by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Watch Closely. Coadministration of CYP3A4 inducers may possibly decrease sufentanil amounts and efficacy, probably precipitating withdrawal syndrome in individuals who definitely have developed physical dependence to sufentanil. Discontinuation of concomitantly utilised CYP3A4 inducers may well raise sufentanil plasma concentration.
pentobarbital will lessen the level or outcome of nitrendipine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Unidentified.